NeuroPace Stock (NASDAQ:NPCE), Quotes and News Summary

Q: What sector and industry does NeuroPace (NPCE) operate in?

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

NeuroPace Stock (NASDAQ: NPCE) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 102.907K
Day Range	- - -
52 Wk Range	3.795 - 18.150
Market Cap	$402.365M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	0.64%
Days to Cover	1.31

Recent News

Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position

Cantor Fitzgerald initiated coverage on NeuroPace Inc (NASDAQ: NPCE), a commercial-stage medical device company focused on drug-resistant epilepsy treatment through the company's responsive neurostimulation device (RNS).

Vandana Singh

Top 5 Health Care Stocks That May Fall Off A Cliff

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Lisa Levin

Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) rose 62.4% to $3.15 in pre-market trading after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on AmerisourceBergen’s third-party marketplace.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About NeuroPace Inc

Sector

Health Care

Industry

Health Care Equipment & Supplies

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of peop...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NeuroPace (NPCE) stock?

You can purchase shares of NeuroPace (NASDAQ: NPCE) through any online brokerage.

View our list of the best stock brokerages.

Who are NeuroPace's (NPCE) competitors?

Other companies in NeuroPace’s space includes: Axogen (NASDAQ:AXGN), SI-BONE (NASDAQ:SIBN), Sight Sciences (NASDAQ:SGHT), Varex Imaging (NASDAQ:VREX) and AngioDynamics (NASDAQ:ANGO).

What is the target price for NeuroPace (NPCE) stock?

The latest price target for NeuroPace (NASDAQ: NPCE) was reported by Wells Fargo on Thursday, March 14, 2024. The analyst firm set a price target for 20.00 expecting NPCE to rise to within 12 months (a possible 42.76% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for NeuroPace (NPCE)?

The stock price for NeuroPace (NASDAQ: NPCE) is $14.01 last updated April 23, 2024 at 4:00 PM EDT.

Does NeuroPace (NPCE) pay a dividend?

There are no upcoming dividends for NeuroPace.

When is NeuroPace (NASDAQ:NPCE) reporting earnings?

NeuroPace’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Is NeuroPace (NPCE) going to split?

There is no upcoming split for NeuroPace.

What sector and industry does NeuroPace (NPCE) operate in?

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-